mosaique.info logo
sign up
  1. home
  3. article
  5. Kimberly-Clark to acquire Kenvue for $48.7 billion

Kimberly-Clark to acquire Kenvue for $48.7 billion

Updated on
ai generated text

Kimberly-Clark is set to purchase Kenvue for roughly $40‑$50 billion, a transaction that has spooked investors as Kenvue shares plunged after the announcement. The buy‑out follows President Trump’s unsubstantiated claim linking autism to Tylenol, intensifying scrutiny over Kenvue’s flagship product.

  1. US
    Kirk Perry
    Kenvue
    1. We stand firmly behind the science and the safety of our products.
    2. These things have been studied for decades, and we continue to stand by that science as the medical community does as well.
    3. One of our challenges at Kenvue right now is we're living in between, which is no place to live – in the murky middle.
  2. US
    Kimberly Forrest
    Bokeh Capital Partners
    1. This validates how easing rate expectations are fueling large, transformational mergers.
    2. Both companies sit side by side on store shelves, so the scale and distribution logic make sense even if the Tylenol overhang remains a shadow any buyer would rather avoid.
  3. US
    Robert Moskow
    TD Cowen
    1. Kimberly-Clark will take on potential litigation risk for the Tylenol brand… This is hard to quantify.
  4. US
    James Harlow
    Novare Capital Management
    1. Most investors expected Kenvue to sell off select brands, not the entire company, given the Tylenol and talc overhangs. But Kimberly-Clark likely saw long-term value in a strong brand portfolio trading at a steep discount.

sources

  1. 1.CNN
  2. 2.Al Jazeera
  3. 3.CNBC
  4. 4.Reuters

perspectives

  1. 1.Mergers and acquisitions
  2. 2.Pharmaceutical

countries

  1. 1.United StatesUS
  2. 2.BrazilBR
  3. 3.Saudi ArabiaSA

organizations

  1. 1.Kenvue
  2. 2.Kimberly-Clark
  3. 3.Bokeh Capital Partners
  4. 4.Johnson & Johnson
  5. 5.Altria
  6. 6.BNP Paribas
  7. 7.British American Tobacco
  8. 8.Dealogic
  9. 9.Electronics Arts
  10. 10.Freedom Capital Markets
  11. 11.Gillette
  12. 12.JPMorgan Chase

persons

  1. 1.Donald TrumpUS
  2. 2.Kirk PerryUS
  3. 3.Mike Hsu
  4. 4.James McPartlandUS
  5. 5.Jay WoodsUS
  6. 6.Ken PaxtonUS
  7. 7.Kimberly ForrestUS
  8. 8.Navann Ty
  9. 9.Robert F Kennedy JrUS
  10. 10.Robert MoskowUS

technicals

  1. 1.Tylenol
  2. 2.Listerine
  3. 3.Aveeno
  4. 4.Clean & Clear
  5. 5.Kleenex
Kimberly-Clark to acquire Kenvue for $48.7 billion